Cboe US - Nasdaq Real Time Price USD

ARK Genomic Revolution ETF (ARKG)

23.83 +0.61 (+2.63%)
At close: 3:59 PM EST
23.83 0.00 (0.00%)
After hours: 4:05 PM EST

Top 10 Holdings (52.77% of Total Assets)

SymbolCompany% Assets
TWST
Twist Bioscience Corporation 8.37%
CRSP
CRISPR Therapeutics AG 7.03%
RXRX
Recursion Pharmaceuticals, Inc. 6.89%
CDNA
CareDx, Inc 5.08%
ADPT
Adaptive Biotechnologies Corporation 4.63%
VCYT
Veracyte, Inc. 4.61%
IONS
Ionis Pharmaceuticals, Inc. 4.39%
NRIX
Nurix Therapeutics, Inc. 4.22%
TXG
10x Genomics, Inc. 3.80%
NTRA
Natera, Inc. 3.75%

Sector Weightings

Overall Portfolio Composition (%)

Stocks 99.85%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.38
Price/Sales 0.19
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ETF Overview

Category Health
Fund Family ARK ETF Trust
Net Assets 1.18B
YTD Daily Total Return -29.23%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers